Sponsor
Novo Nordisk CEO to step down amid market challenges and stock plunge
Posted
Novo Nordisk's CEO, Lars Fruergaard Jorgensen, will step down amidst market challenges and a significant stock price drop, exceeding 50% since June 2024. Increased competition from compounded versions of Ozempic and Wegovy, along with Eli Lilly's Zepbound gaining market share, contributed to the decision.
Zoeken
Categorieën
- National
- International
- Business
- Technology
- Health
- Onderwijs
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Read More
'I won 2020 election by millions of votes': Donald Trump slams Biden’s ‘autopen pardons’, calls Jan 6 probe a 'corrupt and vicious witch hunt'
Donald Trump has once again asserted that the 2020 presidential election was rigged, this time...
Donald Trump to speak to Putin, Zelenskyy on ending Ukraine-Russia ‘bloodbath’
Donald Trump announced plans to engage in telephone conversations with Vladimir Putin and...
Moushumi recalls her past rivalry with Jaya Bachchan
Veteran actress Moushumi Chatterjee recently addressed her controversial remark about being a...
© 2025 Dununu.com : Circle of Life - Santan Social Network
Dutch
